口服来曲唑对绝经后乳腺癌患者血清血管内皮生长因子的影响OACSTPCD
Effect of oral Letrozole treatment on serum vascular endothelial growth factor in postmenopausal breast cancer
目的 通过测定绝经后女性乳腺癌患者口服来曲唑治疗前、后血清血管上皮生长因子(VEGF)的浓度变化,观察血清VEGF与绝经后乳腺癌患者来曲唑疗效之间的相关性.方法 采用酶联免疫吸附法(ELISA)分别检测49例绝经后乳腺癌患者来曲唑治疗前、治疗1年后血清VFGGF水平,并以33名正常健康志愿者血清VEGF水平作为对照.结果 49例绝经后乳腺癌患者服药前血清VEGF水平明显高于对照组(P＜0.01),服用来曲唑治疗1年后血清VEGF显著下降(P＜0.…查看全部>>
Objective To detect the serum vascular endothelial growth factor (VEGF) change before and after oral Letrozole treatment in patients with postmenopausal breast cancer, and observe the correlation between serum VEGF and postmenopausal breast cancer patients with Letrozole therapy. Methods The levels of serum VEGF before and after 1 year Letrozole treatment in 49 cases with postmenopausal breast cancer were detected by enzyme linked immunosorbent assay, and th…查看全部>>
杜雨柔;赵亚东;刘斌;雷星;李建;吴耀禄;除妮妮
延安大学附属医院甲状腺乳腺外科,陕西延安,716000延安大学附属医院甲状腺乳腺外科,陕西延安,716000延安大学附属医院甲状腺乳腺外科,陕西延安,716000延安大学附属医院甲状腺乳腺外科,陕西延安,716000延安大学附属医院甲状腺乳腺外科,陕西延安,716000延安大学附属医院甲状腺乳腺外科,陕西延安,716000延安大学附属医院甲状腺乳腺外科,陕西延安,716000
医药卫生
来曲唑绝经后乳腺癌血管内皮生长因子
Letrozole postmenopausal breast cancer VEGF
《实用临床医药杂志》 2011 (19)
97-98,102,3
评论